Retraction

The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes

Citations (6)

6
Total Citations
0
Post-Retraction
5
Pre-Retraction
0
Same Day
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
From Hypertension to Beyond: Unraveling the Diverse Mechanisms of Olmesartan in Disease Modulation
Laiba Rind, Tarique Mahmood, Mohammed Haris Siddiqui et al. (7 authors)
Drug Research Open Access
Published: Feb 2024
3 citations
7 days before retraction
Exosomes Derived from Quercetin-Treated Bone Marrow Derived Mesenchymal Stem Cells Inhibit the Progression of Osteoarthritis Through Delivering miR-124-3p to Chondrocytes
Shiyu Dong, Genrong Xu, Xiaoliang Li et al. (7 authors)
DNA and Cell Biology
Published: Jan 2024
6 citations
32 days before retraction
Interaction of telmisartan and related sartans with the programmed cell death-ligand 1 (PD-L1) protein dimer: a molecular docking analysis
Gérard Vergoten, Christian Bailly
Future Journal of Pharmaceutical Sciences Open Access
Published: Dec 2023
64 days before retraction
Osteoarthritis and cardiovascular disease: a complicated relationship
А. П. Ребров
South Russian Journal of Therapeutic Practice Open Access
Published: Jun 2023
17 citations
253 days before retraction
Interleukin-10 family members: Biology and role in the bone and joint diseases
Shenghui Ni, Fengping Shan, Jin Geng
International Immunopharmacology
Published: May 2022
24 citations
637 days before retraction
Quick Stats
Total Citations: 10
Years Since Retraction: 1.7 year
Open Access: Yes
Last Checked: Jul 24, 2025